Full Length Research Paper
Abstract
This study aims to describe the antibiotics resistance (antimicrobial resistance [AMR]) profile of Escherichia coli isolates among patients suspected of urinary tract infections (UTIs) at the Souro Sanou University Hospital Center (SSHUC) of Bobo-Dioulasso in Burkina Faso. A descriptive cross-sectional study was conducted from June 1 to August 31, 2021 at SSUHC. An exhaustive sampling was performed and the urine samples of patients suspected of UTIs were collected and subjected to urine analysis and culture. The culture consisted of bacterial isolation, identification, and Antibiotic Susceptibility testing (AST). In this study, 41.88% (178/425) patients were confirmed cases of UTIs. E. coli was involved in 43.8% (78/178) of the UTIs. The frequency of extended-spectrum beta-lactamase producing E. coli isolates was 23% (18/178). The resistance profile of E. coli was 93% for Amoxicillin, 79% for Amoxicillin + Clavulanic acid, 75% for Gentamicin, 70% for Ciprofloxacin, and 53% for Cefotaxime. The study confirmed the predominance of E. coli isolates in ITUs at the referral hospital of Bobo-Dioulasso with high levels of resistance to beta-lactams. There is a need to reduce AMR progression in Burkina Faso by strengthening the AMR surveillance system.
Key words: Resistance, antibiotics, Escherichia coli, urinary tract infections, Bobo-Dioulasso.
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0